<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">66524</article-id><article-id pub-id-type="doi">10.7554/eLife.66524</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-221900"><name><surname>Inoue</surname><given-names>Yusuke</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8075-0597</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-10"/><xref ref-type="other" rid="par-11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180208"><name><surname>Nikolic</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-8"/><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221901"><name><surname>Farnsworth</surname><given-names>Dylan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2402-159X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-239589"><name><surname>Shi</surname><given-names>Rocky</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-239590"><name><surname>Johnson</surname><given-names>Fraser D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221902"><name><surname>Liu</surname><given-names>Alvin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221903"><name><surname>Ladanyi</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-221904"><name><surname>Somwar</surname><given-names>Romel</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180226"><name><surname>Gallo</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-29158"><name><surname>Lockwood</surname><given-names>William W</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9831-3408</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Integrative Oncology</institution>, <institution>British Columbia Cancer Agency</institution>, <addr-line><named-content content-type="city">Vancouver</named-content></addr-line>, <country>Canada</country></aff><aff id="aff2"><institution content-type="dept">Arnie Charbonneau Cancer Institute</institution>, <institution>University of Calgary</institution>, <addr-line><named-content content-type="city">Calgary</named-content></addr-line>, <country>Canada</country></aff><aff id="aff3"><institution content-type="dept">Human Oncology and Pathogenesis Program</institution>, <institution>Memorial Sloan-Kettering Cancer Center</institution>, <addr-line><named-content content-type="city">New York</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-33764"><name><surname>Murphy</surname><given-names>Maureen E</given-names></name><role>Reviewing editor</role><aff><institution>The Wistar Institute</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>wlockwood@bccrc.ca</email> (WL);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>14</day><month>06</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e66524</elocation-id><history><date date-type="received"><day>13</day><month>01</month><year>2021</year></date><date date-type="accepted"><day>11</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement>Â© 2021, Inoue et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Inoue et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-66524-v1.pdf"/><abstract><p>Small-cell lung cancer (SCLC) is neuroendocrine in origin and rarely contains mutations in the MAPK pathway. Likewise, non-SCLC (NSCLC) that transform to SCLC concomitantly with development of therapy resistance downregulate MAPK signaling, suggesting an inverse relationship between pathway activation and lineage state. To test this, we activated MAPK in SCLC through expression of mutant KRAS or EGFR, which revealed suppression of the neuroendocrine differentiation via ERK. We found that ERK induces expression of ETS factors that mediate transformation into a NSCLC-like state. ATAC-seq demonstrated ERK-driven changes in chromatin accessibility at putative regulatory regions and global chromatin rewiring at neuroendocrine and ETS transcriptional targets. Further, induction of ETS factors and suppression of neuroendocrine differentiation were dependent on histone acetyltransferases CBP/p300. Overall, we describe how the ERK-CBP/p300-ETS axis promotes a lineage shift between neuroendocrine and non-neuroendocrine phenotypes and provide rationale for the disruption of this program during transformation-driven resistance to targeted therapy.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>PJT-148725</award-id><principal-award-recipient><name><surname>Lockwood</surname><given-names>William W</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000245</institution-id><institution>Michael Smith Foundation for Health Research</institution></institution-wrap></funding-source><award-id>Scholar Award</award-id><principal-award-recipient><name><surname>Lockwood</surname><given-names>William W</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000024</institution-id><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>New Investigator Award</award-id><principal-award-recipient><name><surname>Lockwood</surname><given-names>William W</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100015752</institution-id><institution>British Columbia Lung Association</institution></institution-wrap></funding-source><award-id>Research Grant</award-id><principal-award-recipient><name><surname>Inoue</surname><given-names>Yusuke</given-names></name><name><surname>Lockwood</surname><given-names>William W</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004376</institution-id><institution>Terry Fox Research Institute</institution></institution-wrap></funding-source><award-id>New Investigator Award</award-id><principal-award-recipient><name><surname>Lockwood</surname><given-names>William W</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Canadian Institutes of Health Research</institution></institution-wrap></funding-source><award-id>PJT-156278</award-id><principal-award-recipient><name><surname>Gallo</surname><given-names>Marco</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001804</institution-id><institution>Canada Research Chairs</institution></institution-wrap></funding-source><award-id>Brain Cancer Epigenomics (Tier 2)</award-id><principal-award-recipient><name><surname>Gallo</surname><given-names>Marco</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007582</institution-id><institution>Alberta Health Services</institution></institution-wrap></funding-source><award-id>Clinician Investigator Program fellowship</award-id><principal-award-recipient><name><surname>Nikolic</surname><given-names>Ana</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009192</institution-id><institution>Alberta Innovates</institution></institution-wrap></funding-source><award-id>Fellowship</award-id><principal-award-recipient><name><surname>Nikolic</surname><given-names>Ana</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100009098</institution-id><institution>Japanese Respiratory Society</institution></institution-wrap></funding-source><award-id>Lilly Oncology Fellowship Program Award</award-id><principal-award-recipient><name><surname>Inoue</surname><given-names>Yusuke</given-names></name></principal-award-recipient></award-group><award-group id="par-11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000245</institution-id><institution>Michael Smith Foundation for Health Research</institution></institution-wrap></funding-source><award-id>Fellowship</award-id><principal-award-recipient><name><surname>Inoue</surname><given-names>Yusuke</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Gene expression data has been deposited to GEO under the accession code GSE160482. ATAC seq data has been deposited to GEO under the accession code GSE160204</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Inoue Y</collab><collab>Nikolic A</collab><collab>Liu A</collab><collab>Ladanyi M</collab><collab>Somwar R</collab><collab>Gallo M</collab><collab>Lockwood WW</collab></person-group><year iso-8601-date="2020">2020</year><source>ATAC-seq of lung cancer cell lines with doxycycline KRAS G12V and drug treatments</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi</ext-link><comment>GEO</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Lockwood WW</collab><collab>Inoue Y</collab></person-group><year iso-8601-date="2020">2020</year><source>Response of SCLC to mutant KRAS or EGFR induction</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi</ext-link><comment>GEO</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-66524-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>